212 related articles for article (PubMed ID: 35942212)
21. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
22. Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer.
Lin Y; Gan F; He X; Deng H; Li Y
J Immunol Res; 2022; 2022():5893998. PubMed ID: 35915656
[TBL] [Abstract][Full Text] [Related]
23. Integrated analysis of long non‑coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.
Wu WJ; Shen Y; Sui J; Li CY; Yang S; Xu SY; Zhang M; Yin LH; Pu YP; Liang GY
Mol Med Rep; 2018 Jun; 17(6):7845-7858. PubMed ID: 29620291
[TBL] [Abstract][Full Text] [Related]
24. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
25. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
26. [Correlation analysis of Poor Prognosis and Immunotherapy of lncRNAs Related with m
Gu R; Liu M; Lin P; Feng TY; Yuan H; Ou DQ; Li SQ; Li Q; Zhao G; Zhang J; Li K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):626-636. PubMed ID: 35871733
[TBL] [Abstract][Full Text] [Related]
27. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
28. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer.
Wu B; Wang K; Fei J; Bao Y; Wang X; Song Z; Chen F; Gao J; Zhong Z
Oncol Rep; 2018 Dec; 40(6):3427-3437. PubMed ID: 30542694
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
30. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
32. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
33. Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting.
Sherif S; Mall R; Almeer H; Naik A; Al Homaid A; Thomas R; Roelands J; Narayanan S; Mohamed MG; Bedri S; Al-Bader SB; Junejo K; Bedognetti D; Hendrickx W; Decock J
J Transl Med; 2022 Sep; 20(1):442. PubMed ID: 36180904
[TBL] [Abstract][Full Text] [Related]
34. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.
Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ
J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740
[TBL] [Abstract][Full Text] [Related]
35. Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database.
Wu W; Sui J; Liu T; Yang S; Xu S; Zhang M; Huang S; Yin L; Pu Y; Liang G
PeerJ; 2019; 7():e6761. PubMed ID: 31065456
[TBL] [Abstract][Full Text] [Related]
36. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
37. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
38. Construction and validation of an immune-related LncRNA prognostic model for hepatocellular carcinoma.
Xin C; Huang B; Chen M; Yan H; Zhu K; Chen L; Jiang C; Zhang J; Wu Y
Cytokine; 2022 Aug; 156():155923. PubMed ID: 35667281
[TBL] [Abstract][Full Text] [Related]
39. Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer.
Zheng J; Cao B; Zhang X; Niu Z; Tong J
Biomed Res Int; 2020; 2020():3641231. PubMed ID: 33274204
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]